Abstract
Cross-contamination is a common cause of adverse food reactions that remains an ongoing challenge for the safety of patients with food allergies, especially those with concurrent diagnoses. It is concerning that oral immunotherapy (OIT) products are often manufactured in shared facilities and may risk cross-contamination. In this study, we explored potential cross-contamination in OIT products manufactured by the Stanford Sean N. Parker Center for Allergy and Asthma Research.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
